Details for New Drug Application (NDA): 085630
✉ Email this page to a colleague
NDA 085630 describes TRICHLOREX, which is a drug marketed by Lannett and is included in two NDAs. Additional details are available on the TRICHLOREX profile page.
The generic ingredient in TRICHLOREX is trichlormethiazide. There is one drug master file entry for this compound. Additional details are available on the trichlormethiazide profile page.
The generic ingredient in TRICHLOREX is trichlormethiazide. There is one drug master file entry for this compound. Additional details are available on the trichlormethiazide profile page.
Summary for 085630
| Tradename: | TRICHLOREX |
| Applicant: | Lannett |
| Ingredient: | trichlormethiazide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 085630
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 4MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
